Michael Wittekind
Nessuna posizione attualmente
Profilo
Michael Wittekind worked as an Executive Director-Research at Amgen, Inc. from 2003 to 2007, an Associate Director at Bristol-Myers Squibb Pharmaceutical Research Institute, and a Chief Scientific Officer & Senior VP-Research at ContraFect Corp.
from 2014 to 2016.
He also worked as a Director-Process Development at Phylos, Inc. Dr. Wittekind holds a doctorate degree from the University of Wisconsin and a graduate degree from the University of Washington.
Precedenti posizioni note di Michael Wittekind
Società | Posizione | Fine |
---|---|---|
CONTRAFECT CORPORATION | Chief Tech/Sci/R&D Officer | 01/10/2016 |
AMGEN INC. | Chief Tech/Sci/R&D Officer | 01/11/2007 |
Bristol-Myers Squibb Pharmaceutical Research Institute | Corporate Officer/Principal | - |
Phylos, Inc.
Phylos, Inc. Miscellaneous Commercial ServicesCommercial Services Phylos, Inc. provides biopharmaceutical research and manufacturing services. The company is headquartered in Lexington, MA. | Corporate Officer/Principal | - |
Formazione di Michael Wittekind
University of Washington | Graduate Degree |
University of Wisconsin | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
AMGEN INC. | Health Technology |
CONTRAFECT CORPORATION | Health Technology |
Aziende private | 2 |
---|---|
Phylos, Inc.
Phylos, Inc. Miscellaneous Commercial ServicesCommercial Services Phylos, Inc. provides biopharmaceutical research and manufacturing services. The company is headquartered in Lexington, MA. | Commercial Services |
Bristol-Myers Squibb Pharmaceutical Research Institute |
- Borsa valori
- Insiders
- Michael Wittekind